Innovations in Human Enablement and Enhancement Technologies

Innovative Brain-Computer Interfaces (BCIs), Exoskeletons, Nootropics and Electroceuticals to Trigger New Growth Opportunities
Share this:
Published: 30 Mar 2016

The overall purpose of human enablement is to restore an impaired function to average levels but mostly to raise the current level that is beyond the norm for humans. The current research service on human enablement covers the most talked about technologies of the present and future - Brain-Computer Interfaces (BCIs), Exoskeletons, Nootropics and Electroceuticals. This research service covers these four technologies in detail, profiling key industry players and their products, their innovation attributes and the factors associated with their likelihood of adoption. The section on impact assessment lists the top industry drivers and challenges that are expected to encourage the adoption of these technologies. The subsequent section on diffusion of innovations provides a detailed breakup of the factors associated with adoption of each of the technologies in three of the most prominent regions of the world - North America, Europe and Asia-Pacific. Finally, the chapter on opportunity analysis recommends some of the key management strategies that must be embraced to boost the current state of human enhancement technologies. This segment also lists some of the key technologies and applications that will begin to make inroads in the global market by 2025.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..